SASODEXA

This brand name is authorized in Nigeria.

Active ingredients

The drug SASODEXA contains one active pharmaceutical ingredient (API):

1	Dexamethasone UNII AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE
	Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.
	Read more about Dexamethasone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100547	Injection	SASODEXA INJECTION INJ 4 mg/mL 1ml x 10 ampoules	43 NF-PP-224552 SASODEXA INJECTION DEXAMETHASONE ( AS SODIUM) INJECTION 4MG/ML Each ml contains: Dexamethasone Sodium phosphate USP Eq. to Dexamethasone phosphate 40mg A4-100547 Drugs Imported Products 1mlx10Ampoules Prescription Only Medicine (POM) 8/8/2021 SASTEK MEGA PHARMA & CHEMICAL COMPANY LTD, 10A ABAYOMI STREET, OFF OLARENWAJU STREET, OREGUN, IKEJA, LAGOS 8036857486 sastekmegapharmachem@gmail.com MAKCUR LABORATORIES LIMITED, 46/5-5-7, VILLAGE-ZAK, TAL-DEHGAM, DIST: GANDHINAGAR- 30 GUJARAT, INDIA, India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB02	Dexamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100547